Hosp. Costa Del Sol

Málaga 29603

0 studies enrolling now · 3 studies all time

What they study most

Chronic Thromboembolic Pulmonary Hypertension, Multiple Myeloma, Pulmonary Arterial Hypertension

Studies at this site

• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension — Stopped early
• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab — Stopped early